¶¶زُ¶جتسئµ

header-logo
GettyImages-609179959-hero
headshot

Binod Dhakal, MD

Associate Professor

view physician profile

Locations

  • Froedtert Hospital
  • Clinical Cancer Center - Froedtert Hospital

Specialties

  • Hematology
  • Medical Oncology

Languages

  • English, Nepali, Hindi

Clinical Cancer Center - Froedtert Hospital

Education

  • MD - Doctor of Medicine

Biography

Binod Dhakal, MD, MS, is Assistant Professor of Medicine, at the ¶¶زُ¶جتسئµ, Division of Hematology, specializing in multiple myeloma and plasma cell disorders. He graduated from Manipal College of Medical Sciences, Pokhara Nepal in 2004, completed Internal Medicine Residency at Saint Francis Hospital Evanston Illinois, and a fellowship in hematology/oncology at the ¶¶زُ¶جتسئµ, where he also served as a Chief Fellow. Prior to joining the fellowship, he was Assistant Professor of Medicine at the Medical College in Wisconsin in the Division of General Internal Medicine. He has authored numerous publications, including journal articles, meeting abstracts and book chapters. He has also won several awards during his fellowship which include the American Society of Clinical Oncology (ASCO) Merit Award; ¶¶زُ¶جتسئµ Affiliated Hospitals (¶¶زُ¶جتسئµAH) research award; Central Society for Clinical and Translational Research (CSCTR) best oral abstract and travel trainee award; American Society for Blood and Marrow Transplantation (ASBMT) clinical research training course; and, Outstanding Medical School Teacher award. Additionally, he was the recipient of the Mazie Froedtert Willms and Sue Froedtert Cancer Scholarship, and obtained his Master’s Degree in Clinical and Translational Science.

Research Interests

Dr. Dhakal's current research interests focus on novel drug treatments for patients with multiple myeloma and related plasma cell disorders by designing and conducting early phase clinical trials.

Publications

  • (Giri S, Dhakal B, Callander NS, Medvedova E, Godby K, Dholaria BR, Bal S, Ravi G, Chhabra S, Silbermann RW, Costa L.) Blood. 2025 Aug 07;146(6):707-716 PMID: 40193714 SCOPUS ID: 2-s2.0-105006948795 04/07/2025

  • (Touzeau C, Lipe B, Khan AM, Dhakal B, Nair S, He J, Mendes J, Lee S, Lonardi C, Slaughter A, Lendvai N, Schecter JM, Chen D, Zhao M, Yeh TM, Leleu X, Puig N, Dytfeld D, Zamagni E, Weisel K, Karlin L, Delforge M, Corradini P, Mina R, Roeloffzen W, Sidana S.) Adv Ther. 2025 Aug 06 PMID: 40768190 08/06/2025

  • (Dhakal B, Akhtar OS, Fandrei D, Jensen A, Banerjee R, Pan D, Richard S, Friend R, Rees MJ, Costello P, Vazquez Martinez MA, Pasvolsky O, Wagner CB, Davis JA, Castaneda Puglianini OA, Reshef R, Afrough A, Dima D, Bhutani M, Nadeem O, Parrondo RD, Freeman CL, Mikkilineni L, Raza S, Anderson LD Jr, Kapoor P, Hosoya H, Chhabra S, Grajales-Cruz A, Gaballa MR, Midha S, Alsina M, Sborov DW, Patel KK, Lin Y, Ferreri CJ, Gagelmann N, Kumar AD, Hansen DK, Cowan AJ, Costa LJ, Merz M, Sidana S.) Blood. 2025 Aug 01 PMID: 40749169 08/01/2025

  • (Dhakal B, Einsele H, Schecter JM, Deraedt W, Lendvai N, Slaughter A, Lonardi C, Nair S, Varghese NE, He J, Kharat A, Lee S, Cost P, Potluri R, Koneru M, Patel N, Florendo E, Rodriguez-Otero P, Yong K.) Cancer Med. 2025 Aug;14(15):e71093 PMID: 40719208 PMCID: PMC12301936 07/28/2025

  • (Kasomva K, Yadav K, Janz S, Dhakal B, Rao S.) Blood Adv. 2025 Jul 17 PMID: 40674709 07/17/2025

  • (Shrestha A, Thanendrarajan S, Bag A, Dhakal B, Zangari M, Al Hadidi S, van Rhee F, D'Souza A, Shah N, Shah MR, Mohan M, Schinke C.) Blood Adv. 2025 Jul 17 PMID: 40674710 07/17/2025

  • (Yadav K, Mohan M, Wagner C, Chakraborty R, Sborov D, Godara A, McClune B, Schinke C, Dhakal B, D'Souza A, Szabo A, Mohyuddin GR.) Leukemia. 2025 Jul 16 PMID: 40670671 07/17/2025

  • (Sidana S, Ahmed N, Akhtar OS, Brazauskas R, Oloyede T, Bye M, Hansen D, Ferreri C, Freeman CL, Afrough A, Anderson LD Jr, Dhakal B, Dhanda D, Gowda L, Hashmi H, Harrison MJ, Kitali A, Landau H, Mirza AS, Patwardhan P, Qazilbash M, Usmani S, Patel K, Nishihori T, Ganguly S, Pasquini MC.) Blood. 2025 Jul 10;146(2):167-177 PMID: 40198886 SCOPUS ID: 2-s2.0-105004741731 04/09/2025

  • (Jagannath S, Martin TG, Lin Y, Cohen AD, Raje N, Htut M, Deol A, Agha M, Berdeja JG, Lesokhin AM, Liegel JJ, Rossi A, Lieberman-Cribbin A, Usmani SZ, Dhakal B, Parekh S, Li H, Wang F, Montes de Oca R, Plaks V, Sun H, Banerjee A, Schecter JM, Lendvai N, Madduri D, Lengil T, Zhu J, Koneru M, Akram M, Patel N, Costa Filho O, Jakubowiak AJ, Voorhees PM.) J Clin Oncol. 2025 Jun 03:JCO2500760 PMID: 40459151 06/03/2025

  • (Biran N, Dhakal B, Niesvizky R, Lentzsch S, Bhutani D, McKay JT, Vesole DH, Nooka A, Paul B, Hari PN, D'Ambrosi S, Kuiper R, van Vliet M, Siegel D, Usmani SZ, van Rhee F.) Br J Haematol. 2025 Jun;206(6):1642-1653 PMID: 40231946 SCOPUS ID: 2-s2.0-105002595395 04/15/2025

  • (Mohan M, Szabo A, Cheruvalath H, Clennon A, Bhatlapenumarthi V, Patwari A, Balev M, Bhutani D, Shrestha A, Thanendrarajan S, Dhakal B, Zangari M, Trikannad A, Vellanki S, Al-Hadidi S, Lentzsch S, van Rhee F, Bag A, D'Souza A, Shah N, Chakraborty R, Shah MR, Schinke C.) Blood Cancer J. 2025 Apr 23;15(1):74 PMID: 40268898 PMCID: PMC12018942 SCOPUS ID: 2-s2.0-105003139880 04/24/2025

  • (Bal S, Magnusson T, Ravi G, Giri S, Godby K, Dhakal B, Callander NS, Silbermann RW, Dholaria B, Reddy VB, Costa LJ.) Blood Cancer J. 2025 Apr 23;15(1):73 PMID: 40268941 PMCID: PMC12019237 SCOPUS ID: 2-s2.0-105003126302 04/24/2025

Publications of from the

© 2025 ¶¶زُ¶جتسئµ.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination, Anti-Harassment, and Legal Compliance Statement
The ¶¶زُ¶جتسئµ (¶¶زُ¶جتسئµ) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, military status, or other legally protected classification. ¶¶زُ¶جتسئµ maintains full compliance with all applicable federal, state, and local laws and regulations in pursuit of our missions. Consistent with federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making.

¶¶زُ¶جتسئµ's policies, federal and state laws, and regulations prohibit unlawful discrimination and harassment. Employees, learners, students, applicants, or other members of the ¶¶زُ¶جتسئµ community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic.